ArticleNeuropsychiatric disease and treatment2013

Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.

Alessandra Lugaresi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.